Craft

Double Bond Pharmaceutical

Stock Price

$0.4

2021-10-01

Market Capitalization

$5.4 M

2021-10-01

Revenue

KR84 K

FY, 2025

Double Bond Pharmaceutical Summary

Company Summary

Overview
Double Bond Pharmaceutical is a company that develops approaches for treatment of cancers. It focuses on the treatment of severe forms of cancer, asthma, diabetes, infections and autoimmune diseases.
Type
Public
Status
Active
Founded
2014
HQ
Uppsala, SE | view all locations
Website
https://www.doublebp.com
Cybersecurity rating
Sectors

Key People

  • Sergey Yanitsky

    Sergey Yanitsky, Board Member

    • Igor Lokot

      Igor Lokot, Board Member & Company President

      LocationsView all

      2 locations detected

      • Uppsala, Uppsala län HQ

        Sweden

        Rapsgatan 7

      • Uppsala, Uppsala län

        Sweden

        Virdings allé 32B, 75

      Double Bond Pharmaceutical Financials

      Summary Financials

      Revenue (FY, 2025)
      kr84.0K
      Gross profit (FY, 2025)
      (kr25.0K)
      Net income (FY, 2025)
      (kr333.0K)
      Cash (FY, 2025)
      kr1.1M
      EBIT (FY, 2025)
      kr448.0K

      Footer menu